VEOX, NCT01386346: Epigenetic Priming Using Azacitidine With Neoadjuvant Chemotherapy for Resectable Esophageal Cancer |
|
|
| Completed | 1 | 12 | US | Azacitidine, Vidaza®, 5-Azacitidine, Oxaliplatin, Eloxatin, Epirubicin, Ellence, Capecitabine, Xeolda | Weill Medical College of Cornell University, Celgene Corporation | Esophageal Cancer, Malignant Neoplasm of Cardio-esophageal Junction of Stomach | 08/14 | 09/18 | | |
